Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
1.
J Obstet Gynaecol ; 35(6): 570-7, 2015.
Artículo en Inglés | MEDLINE | ID: mdl-25517017

RESUMEN

Women with pre-term pre-labour rupture of membranes (PPROM) 22-33 weeks' gestation were included in a retrospective cohort study with a structured audit to identify risk factors of major complications following PPROM and to assess whether these complications are predictable. Of the 234 women analysed, 106 (45%) delivered within three days. Eighty-four women (36%) had at least one major complication and 45% of these complications occurred within three days. The complication rate was 64% in early PPROM before 28 weeks' gestation and 11% in late PPROM at 28 weeks' gestation or later. Nulliparous women had an increased risk of major complications (adjusted hazards ratio: 3.07 (95% confidence interval: 1.28-7.37)). The complication rates were highest in early PPROM and during the first three days after PPROM. Multiparous women with late PPROM, who do not deliver within the first three days, have the lowest risk of major complications and are suitable for home care.


Asunto(s)
Rotura Prematura de Membranas Fetales/terapia , Complicaciones del Embarazo/terapia , Resultado del Embarazo , Adulto , Estudios de Cohortes , Femenino , Edad Gestacional , Humanos , Recién Nacido , Paridad , Embarazo , Complicaciones del Embarazo/epidemiología , Estudios Retrospectivos , Factores de Riesgo , Tocólisis
2.
Thromb Haemost ; 112(1): 73-8, 2014 Jul 03.
Artículo en Inglés | MEDLINE | ID: mdl-24499991

RESUMEN

Estimating the risk of venous thromboembolism (VTE) associated with combined hormonal contraceptives following early terminated pregnancies or birth, a Danish nationwide retrospective cohort observing a one-year follow-up was defined using three unique registries. All Danish women with confirmed pregnancies aged 15-49 during the period of 1995-2009 were included. The main outcomes were relative and absolute risks of first time venous thromboembolism in users as well as non-users of combined hormonal contraceptives. In 985,569 person-years, 598 venous thromboembolisms were recorded. After early terminated pregnancies and births, respectively, 113 and 485 events occurred in 212,552 and 773,017 person-years. After early terminated pregnancies, the crude VTE incidence ratios were similar, and the numbers needed to harm were equal between groups that did or did not use combined hormonal contraceptives throughout the follow-up year. After childbirth, individuals that used combined hormonal contraceptives were more likely than non-users to experience VTE depicted by crude incidence ratios; however, the difference was only significant after 14 weeks. This implied that the numbers needed to harm were lower for those that used compared to those that did not use combined oral contraceptives in the initial 14 weeks postpartum. In conclusion, the use of combined hormonal contraceptives after early terminated pregnancies was not detrimental, but during the puerperal period, they should be used with caution.


Asunto(s)
Aborto Inducido/estadística & datos numéricos , Anticonceptivos Hormonales Orales/administración & dosificación , Tromboembolia Venosa/epidemiología , Adolescente , Adulto , Estudios de Cohortes , Anticonceptivos Hormonales Orales/efectos adversos , Dinamarca , Femenino , Estudios de Seguimiento , Humanos , Incidencia , Persona de Mediana Edad , Periodo Posparto , Sistema de Registros , Estudios Retrospectivos , Riesgo , Resultado del Tratamiento , Tromboembolia Venosa/inducido químicamente , Tromboembolia Venosa/prevención & control , Adulto Joven
3.
Acta Obstet Gynecol Scand ; 85(4): 467-75, 2006.
Artículo en Inglés | MEDLINE | ID: mdl-16612710

RESUMEN

OBJECTIVE: To assess the occurrence of spontaneous abortion, comparing two different data sources. To estimate the rate of spontaneous abortion over a 2-year period, and examine potential predictors of the risk for incident spontaneous abortion. METHODS: We used interview data from a population-based prospective cohort study comprising 11,088 women and data from a linkage of the cohort with the Hospital Discharge Register to compare spontaneous abortions as reported in the interview with those identified in the register. Based on interview data, we estimated the rate of spontaneous abortion during the two-year follow-up. Finally, risk determinants for incident spontaneous abortion were analyzed by means of logistic regression. RESULTS: A total of 654 spontaneous abortions before enrolment in the study were reported by the women compared to 531 abortions found in the register. More than 80% of the spontaneous abortions identified from both sources were recorded in the same year. During follow-up a total of 20.9% of pregnancies intended to be carried to term ended as a spontaneous abortion. In the risk factor analysis, we found that previous spontaneous abortion, being single, never having used oral contraceptives, and use of intrauterine device were associated with increased risk of subsequent spontaneous abortion. In addition, it was indicated that a short interpregnancy interval following a spontaneous abortion may confer an increased risk of abortion in the subsequent pregnancy. CONCLUSION: We found a high rate of spontaneous abortion in the present study and an acceptable agreement between information obtained by interview and register information. More than 25% of the spontaneous abortions were only reported by the women, and this could not be explained by erroneously reported induced abortions, and may be early, nonhospitalized abortions. We confirm that number of previous spontaneous abortions is a strong determinant, and our data may also indicate a role of previous contraceptive habits. A role of the length of interpregnancy interval in the risk of spontaneous abortion cannot be ruled out.


Asunto(s)
Aborto Espontáneo/epidemiología , Aborto Espontáneo/etiología , Sistema de Registros/estadística & datos numéricos , Adulto , Anticoncepción , Dinamarca , Femenino , Humanos , Embarazo , Estudios Prospectivos , Recurrencia , Sistema de Registros/normas , Factores de Riesgo
4.
Hum Reprod ; 18(12): 2704-10, 2003 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-14645195

RESUMEN

BACKGROUND: Consumption of caffeine and alcohol is suspected to affect pregnancy outcome. Use of both stimulants is widespread and even minor effects on fetal viability are of public health interest. METHODS: We performed a nested case-control study using prospective data from a population-based cohort comprising 11088 women aged 20-29 years. From this cohort, women who experienced either a spontaneous abortion (n = 303) or who gave birth (n = 1381) during follow-up [mean time: 2.1 years (range: 1.6-3.4)] were selected. Associations between self-reported exposures to caffeine and/or alcohol at enrolment and spontaneous abortion were analysed by means of logistic regression. RESULTS: Compared with women with a pre-pregnancy intake of <75 mg caffeine per day, the adjusted odds ratio (95% confidence interval) for spontaneous abortion was 1.26 (0.77-2.06), 1.45 (0.87-2.41), 1.44 (0.87-2.37) and 1.72 (1.00-2.96) for a pre-pregnancy intake on 75-300, 301-500, 501-900 and >900 mg caffeine per day respectively (P = 0.05 for trend). A pre-pregnancy intake of alcohol was not a predictor for spontaneous abortion. CONCLUSIONS: A high intake of caffeine prior to pregnancy seems to be associated with an increased risk of spontaneous abortion, whereas a low-to-moderate alcohol intake does not influence the risk.


Asunto(s)
Aborto Espontáneo/epidemiología , Cafeína/efectos adversos , Etanol/efectos adversos , Adulto , Cafeína/administración & dosificación , Estudios de Casos y Controles , Estudios de Cohortes , Etanol/administración & dosificación , Femenino , Humanos , Modelos Logísticos , Oportunidad Relativa , Atención Preconceptiva , Embarazo , Estudios Prospectivos
5.
Hum Reprod ; 16(11): 2418-21, 2001 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-11679531

RESUMEN

BACKGROUND: The present study was performed to evaluate the prevalence and possible associated risk factors for adenomyosis. METHODS: Medical records were retrieved and histo-pathological material re-examined for 549 consecutive women undergoing hysterectomy in a two-year period from 1990-1991. RESULTS: The prevalence of adenomyosis in the study varied from 10.0-18.2%, depending on different diagnostic criteria. The presence of endometrial hyperplasia at the time of hysterectomy was the only variable significantly associated with adenomyosis (OR = 3.0; 95% CI: 1.2-8.3). No statistically significant association was found between adenomyosis and previous caesarean section, endometrial curettage or evacuation of the uterus. Furthermore, we did not see any significant association between adenomyosis and pain-related symptoms, indication for hysterectomy, age, parity or number of myometrial samples. CONCLUSIONS: Our study stresses the need for precise diagnostic criteria for adenomyosis, and furthermore indicates that endometrial hyperplasia and adenomyosis may have a common aetiology.


Asunto(s)
Endometriosis/epidemiología , Histerectomía , Adulto , Cesárea/efectos adversos , Legrado/efectos adversos , Hiperplasia Endometrial/epidemiología , Hiperplasia Endometrial/etiología , Endometriosis/etiología , Endometriosis/patología , Femenino , Humanos , Persona de Mediana Edad , Factores de Riesgo
6.
Acta Obstet Gynecol Scand ; 78(9): 749-57, 1999 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-10535335

RESUMEN

BACKGROUND: Iron supplementation in pregnancy is a controversial issue. The aim of this review was to summarize the results of relevant papers on this subject. METHODS: Placebo-controlled studies on iron treatment in pregnancy were identified from the Cochrane database. RESULTS: Among fertile women, 20% have iron reserves of >500 mg, which is the required minimum during pregnancy; 40% have iron stores of 100-500 mg, and 40% have virtually no iron stores. The demand for absorbed iron increases from 0.8 mg/day in early pregnancy to 7.5 mg/day in late pregnancy. Dietary iron intake in fertile women is median 9 mg/day, i.e. the majority of women have an intake below the estimated allowance of 12 18 mg/day. Iron absorption increases in pregnancy, but not enough to prevent iron deficiency anemia in 20%, of women not taking supplementary iron. Iron-treated pregnant women have greater iron reserves, higher hemoglobin levels, and a lower prevalence of iron deficiency anemia than placebo-treated women both in pregnancy as well as postpartum. Furthermore, children born to iron-treated mothers have higher serum ferritin levels than those born to placebo-treated mothers. An iron supplement of 65 mg/day from 20 weeks of gestation is adequate to prevent iron deficiency anemia. CONCLUSIONS: In order to avoid iron deficiency in pregnancy, prophylactic iron supplement should be considered. Iron supplements may be administered on a general or selective basis. The selective approach implies screening with serum ferritin in early pregnancy, in order to identify women who can manage without prophylactic iron.


Asunto(s)
Anemia Ferropénica/prevención & control , Suplementos Dietéticos , Hierro de la Dieta/administración & dosificación , Complicaciones del Embarazo/prevención & control , Adulto , Anemia Ferropénica/sangre , Anemia Ferropénica/epidemiología , Anemia Ferropénica/metabolismo , Ensayos Clínicos como Asunto , Suplementos Dietéticos/efectos adversos , Eritrocitos/metabolismo , Eritropoyetina/sangre , Femenino , Ferritinas/sangre , Hemoglobinas/metabolismo , Humanos , Recién Nacido/sangre , Recién Nacido/metabolismo , Hierro de la Dieta/efectos adversos , Hierro de la Dieta/sangre , Hierro de la Dieta/metabolismo , Periodo Posparto/sangre , Embarazo , Complicaciones del Embarazo/sangre , Complicaciones del Embarazo/epidemiología , Complicaciones del Embarazo/metabolismo , Prevalencia , Receptores de Transferrina/biosíntesis , Factores de Tiempo
7.
Ugeskr Laeger ; 159(41): 6057-62, 1997 Oct 06.
Artículo en Danés | MEDLINE | ID: mdl-9381577

RESUMEN

Among fertile, nonpregnant, Danish women, 33% have absent or reduced iron stores; 22% have serum ferritin values above 70 micrograms/l, i.e., iron reserves of more than 530 mg, corresponding to the net iron losses during a normal pregnancy. During pregnancy, the demands for absorbed iron increase from 0.8 to 7.5 mg/day. Controlled studies show that iron-treated pregnant women have higher serum ferritin levels, i.e., larger iron stores, and higher haemoglobin levels than placebo-treated women. A supplement of 66 mg ferrous iron daily from the beginning of the 2nd trimester prevents iron deficiency anaemia. In Denmark, general iron prophylaxis with 60-70 mg ferrous iron daily from 20 weeks of gestation is recommended by the health authorities.


Asunto(s)
Anemia Ferropénica/prevención & control , Hierro/administración & dosificación , Complicaciones Hematológicas del Embarazo/prevención & control , Anemia Ferropénica/epidemiología , Dinamarca/epidemiología , Femenino , Ferritinas/sangre , Humanos , Hierro/sangre , Deficiencias de Hierro , Embarazo , Complicaciones Hematológicas del Embarazo/tratamiento farmacológico
8.
Eur J Surg Oncol ; 22(2): 199-200, 1996 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-8608843

RESUMEN

A case of primary carcinoid in the female breast is reported. The patient was treated by segmental mastectomy and is without local recurrence and signs of carcinoid tumour at any other site after 3 years of observation.


Asunto(s)
Neoplasias de la Mama , Tumor Carcinoide , Femenino , Humanos , Persona de Mediana Edad
9.
Ugeskr Laeger ; 154(14): 938-9, 1992 Mar 30.
Artículo en Danés | MEDLINE | ID: mdl-1580004

RESUMEN

At emergency laparotomy after a fall bleeding from injuries to the upper pole and from lacerations involving the hilum of the spleen were found in a 2 1/2-year-old girl. Partial splenectomy using a linear stapler allowed preservation of the lower pole with intact vessels. Observed peroperatively for 10 minutes, the splenic remnant retrained a macroscopically normal appearance. Blood transfusion was avoided and drainage postoperatively comprised no more than 25 ml serosanguineous fluid. Provided intact splenic capsule can be used for the line of resection, partial splenectomy using a linear stapler seems to be a safe method.


Asunto(s)
Esplenectomía/métodos , Engrapadoras Quirúrgicas , Accidentes por Caídas , Preescolar , Urgencias Médicas , Femenino , Humanos , Bazo/diagnóstico por imagen , Bazo/lesiones , Ultrasonografía
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...